Analysis of the depth of coverage in the targeted SOX17 region indicated nearly 100% of gnomAD samples and a slightly lower percentage of PAH-CHD samples attained read depths of at least 10 (Additional file 1: Figure S2), excluding the possibility that the association is driven by coverage difference between cases and population data. The gene discussed is SOX17; the disease is coronary artery disorder.